EP3793517
PHARMACEUTICAL FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.5.2019EP published:
19.4.2023EP application number:
19728321.1
EPO information:
European Patent Register
Max expiry date:
14.5.2039
Title in English:
PHARMACEUTICAL FORMULATIONLanguage of the patent:
English
Timeline
Today
15.5.2019EP application
19.4.2023EP Publication
Owner
Name:
Klaria Pharma Holding ABAddress:
Virdings Allé 2, 754 50 Uppsala, SE
Inventor
Name:
BOYER, ScottAddress:
754 50 Uppsala, SE
Name:
HÜBINETTE, FredrikAddress:
754 50 Uppsala, SE
Name:
SINGH, ShaliniAddress:
754 50 Uppsala, SE
Priority
Number:
201807942Date:
16.5.2018Country:
GB
Classification
Categories:
A61K 9/00, A61K 9/70, A61K 47/36, A61K 31/352